To get the latest experience from our website, please upgrade your browser.
If people knew about the side effects of a drug, would they still take it? Here’s the thing. Consumers are the guinea pigs when being prescribed a new type of medication — especially when the FDA identified potentially significant risks [...]Read More
Express Scripts — one of the largest pharmacy benefit managers in the U.S. — excluded diabetes drugs Onglyza (saxagliptin) and Kombiglyze XR (saxagliptin and metformin extended release) from its 2017 [...]
When you or someone you love suffers an illness or injury due to the use of a medication or device that was supposed to make you well, you are going [...]
Plaintiffs who say Ethicon’s Physiomesh Composite hernia mesh left them with serious injuries petitioned the court to consolidate lawsuits in Florida. On March 9, 2017, plaintiffs filed a Motion for [...]
A Texas man filed a lawsuit against Bristol-Myers Squibb and AstraZeneca claiming the Type 2 diabetes drug Onglyza (saxagliptin) caused heart failure, according to court documents. According to Wrendell Chester’s [...]
On Feb. 17, 2017, the Brazilian regulatory agency Agencia Nacional da Vigilancia Sanitaria (ANVISA) became the first to suspend sales and recall the Essure medical device, a pair of multi-material [...]